Article
Original Article

Anu Glory Abraham1 , Puvaneswari K2

1: Msc(N) Student, 2: Professor

Narayana Hrudayalaya College of Nursing, Bommasandra, Bangalore - 560099

Author for correspondence

Puvaneswari K

Professor, Dept of Medical surgical Nursing,

Narayana Hrudayalaya College of Nursing ,

Bommasandra, Bangalore-560099

Mobile : 9448126938

Email- puvaneswariramesh@gmail.com 

Received Date: 2019-10-15,
Accepted Date: 2019-11-19,
Published Date: 2019-12-31
Year: 2019, Volume: 9, Issue: 2, Page no. 60-67, DOI: 10.26715/rjns.9_2_6
Views: 677, Downloads: 27
Licensing Information:
CC BY NC 4.0 ICON
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0.
Abstract

INTRODUCTION: Among patients with cardiac disease, anxiety can be functionally appropriate when it prompts an individual to quickly seek treatment for acute cardiac signs and symptoms. Presently, about 3.0 million Percutaneous Transluminal Coronary Angioplasty (PTCA) procedures are performed each year worldwide. The study showed that, although PTCA procedure is minimally invasive, patients experience more anxiety. Research has shown that complementary therapy has the main role in the reduction of anxiety in PTCA patients.

METHODS: A quantitative research approach with true experimental research comprising of pre-test-post-test with control group design was adopted to assess the level of anxiety, the effect of aromatherapy on anxiety and to find an association between anxiety and baseline variables. Ninety patients were selected using a simple random sampling technique in a tertiary cardiac care hospital. The tools used for the study were baseline, clinical variables, and the Beck Anxiety Inventory scale.

RESULTS: Analysis of the effectiveness of aromatherapy on anxiety among PTCA patients revealed that the mean pre interventional anxiety score was 32.11, whereas the mean post interventional anxiety score was 14.78. The calculated t value (t=18.22) was significant at the 0.05 level.

CONCLUSION: The aromatherapy had a positive effect on reducing anxiety, among patients undergoing PTCA, therefore, it may be used as an independent nursing intervention.

<p><strong>INTRODUCTION:</strong> Among patients with cardiac disease, anxiety can be functionally appropriate when it prompts an individual to quickly seek treatment for acute cardiac signs and symptoms. Presently, about 3.0 million Percutaneous Transluminal Coronary Angioplasty (PTCA) procedures are performed each year worldwide. The study showed that, although PTCA procedure is minimally invasive, patients experience more anxiety. Research has shown that complementary therapy has the main role in the reduction of anxiety in PTCA patients.</p> <p><strong>METHODS:</strong> A quantitative research approach with true experimental research comprising of pre-test-post-test with control group design was adopted to assess the level of anxiety, the effect of aromatherapy on anxiety and to find an association between anxiety and baseline variables. Ninety patients were selected using a simple random sampling technique in a tertiary cardiac care hospital. The tools used for the study were baseline, clinical variables, and the Beck Anxiety Inventory scale.</p> <p><strong>RESULTS:</strong> Analysis of the effectiveness of aromatherapy on anxiety among PTCA patients revealed that the mean pre interventional anxiety score was 32.11, whereas the mean post interventional anxiety score was 14.78. The calculated t value (t=18.22) was significant at the 0.05 level.</p> <p><strong>CONCLUSION:</strong> The aromatherapy had a positive effect on reducing anxiety, among patients undergoing PTCA, therefore, it may be used as an independent nursing intervention.</p>
Keywords
Anxiety, Aromatherapy, PTCA, Cardiac diseases, Inhalation, clinical variable
Downloads
  • 1
    FullTextPDF
Article

INTRODUCTION

Coronary artery diseases (CAD) such as Myocardial infarction and Angina pectoris have increased recently as the population ages and as changes in eating habits and lifestyle have led to higher incidences of diabetes, high blood pressure, and hyperlipidaemia.1The prevalence of the disease had significant implications on its workforce—it was estimated that 28% among 5 million Indians died of cardiovascular disease every year, are less than the age of 65 years and almost 25% of heart attacks seemed to occur under the age of early 40's.2 PTCA and stent insertion using coronary angiography are important procedures for determining the location and severity of the blocked artery, and they can play an important role in determining subsequent treatment methods.3 The National Interventional Council (NIC) reported in India, during 2015, NIC performed 3.75 lakh angioplasties.4 These procedures generally lead to hospitalization in an intensive care unit (ICU).

Most of these patients experience the physical effects of a heart examination as well as an unfamiliar environment, isolation from family, and stress from encountering strangers. Consequently, most patients experience a relatively severe level of psychological anxiety because of the loss of individuality due to the treatment-centric environment and a sense of crisis due to the constantly changing environment.5 Anxiety is a factor that negatively influences the recovery after cardiac events.

The prevalence of anxiety is high at approximately 70% to 80% among patients who have experienced an acute cardiac event.6 Nursing interventions based on education before coronary angiography or PTCA have shown to be effective before the procedure has been implemented in the clinical setting.1 Aromatherapy, which has a wide range of applications and is easy to deploy, has recently garnered much attention. The inhalation aromatherapy has positive effects on reducing anxiety in patients before the invasive procedure, also which is recommended as a new and easy alternative for nurses to reduce anxiety in the patients.7

A study conducted among fourteen female patients with chronic renal failure were significantly decreased the mean scores of the Hamilton Rating Scale for Anxiety (HAMA) with lavender aroma.8 Lavender aromatherapy was shown to reduce anxiety in patients in the coronary intensive care unit (ICU),9 dental office,10 after myocardial infarction11and PTCA.12 A quasiexperimental study evaluated the effectiveness of aromatherapy rubbed on a handkerchief and inhaled by the patient for 20 minutes in preoperative anxiety. The mean level of anxiety in pre-intervention in the case group was 51.00 that decreased to 38.61 after intervention which showed significant reduction of anxiety.7 Since very few studies were done on aromatherapy on anxious PTCA patients, the researcher was interested to assess the level of anxiety among patients undergoing PTCA, to assess the effectiveness of aromatherapy on anxiety among patients undergoing PTCA and to determine the association between the pre interventional level of anxiety with selected baseline variables.

MATERIALS AND METHODS

A quantitative research approach with true experimental research comprising of pre-testpost-test with control group design was adopted for this study. The setting for this study was the tertiary cardiac care hospital, Bangalore which performs approximately 4 to 6 cases of PTCA per day. In this study, 90 patients with moderate or severe anxiety were selected using Becks Anxiety Inventory in a pre-test. Then the sample was categorized to Experimental-45 and Control-45 using simple random sampling (lottery method). The researcher has adopted the WEIDENBACH'S helping art at clinical nursing theory (1964) as a base of developing the conceptual framework. This is a prescriptive theory in nursing that had a central purpose which direct action towards an expected goal.12 The tools used for the study were baseline (Age, Gender, Marital status, Education, Occupation, Habits, Place of living, Previous history of hospitalization and Previous history of surgery/Invasive procedure), clinical (Systolic blood pressure, Pulse /minute, Respiratory rate/ minute) variables and Beck anxiety Inventory scale (21components with a 4 point scale) The Beck Anxiety Inventory Scale is psychometrically sound. Internal consistency (Cronbach's alpha) ranges from 0.92 to 0.94. The CVI for baseline and clinical variables was 0.83. Ethical clearance from the Institutional Ethics Committee and written informed consent from the participants of the study were obtained. Then the data were collected with the intervention protocol (Table-1).

RESULTS

Data were analyzed using SPSS. The results were computed using descriptive and inferential statistics.

Findings related to the frequency and percentage distribution of baseline and clinical variables

The table - 2 depicted that the majority of the subjects were between the age group of 50-59 years in both groups. Most of them were male and married in both groups. Based on the distribution of education around 24% of subjects had a high school education in both groups. The majority of them i.e. 69% and 47% were moderate workers in both experimental and control group respectively. Almost half of the subjects in both groups had no bad habits. And most of them 60% and 67% of patients were from rural areas in the experimental and control group respectively. Almost 62% in experimental and 58% in control had a previous history of hospitalization. Similarly, 56% in experimental and 60% in control had no history previous of surgery/invasive procedure.

Figure 1-3 depicted the frequency and percentage distribution of clinical variables, 53% in the experimental and 60% in the control were had the systolic blood pressure of 121-140 mm of Hg. Almost half of the patients recorded the pulse rate between 71-80 beats/mt. Regarding the respiratory rate, 40% of patients were recorded between 19-20 beats/mt in the experimental and 17-18 beats/mt in the control group.

Findings related to Assessment of the level of anxiety among the experimental and control group

Table 3 Showed that during pre-intervention, in the experimental group 76% of subjects reported moderate anxiety, 24% of patients reported severe anxiety. Whereas in the post-intervention the anxiety came down i.e. 73% of patients reported low anxiety and remaining reported moderate anxiety. In the control group during pre-intervention, 81% reported moderate anxiety, and 19% reported severe anxiety. Whereas in the post-intervention, 93% reported moderate anxiety and 7% had severe anxiety.

Table- 4 showed the mean (S.D) of anxiety scores. In the experimental group, the pre-interventional anxiety was 32.11(3.63) and the post-interventional score was 14.78(6.62). In the control group, the pre-interventional anxiety was 32.11(3.52) and the post-interventional score was 29.42 (3.77).

Findings related to the Effectiveness of aromatherapy in anxiety among PTCA patients in the experimental group

The table 5, showed that the mean value of pre and post-intervention scores of the experimental group was 32.11and 14.78 respectively with a t-value of 18.22. It was found to be significant at 0.05 level, thus the hypothesis H1 was accepted and the null hypothesis was rejected

Findings related to the Effectiveness of aromatherapy in anxiety among PTCA patients in experimental and control

Table 6 showed that the mean (S.D) postinterventional score was 14.78(6.62) among the experimental group and the 29.42 (3.78) among the control group with the mean difference of 14.64. The 't'-value 12.887 was found to be significant at the 0.05 level between the experimental and control group. Hence the hypothesis H2 was accepted at 0.05 level of significance and the null hypothesis rejected.

Findings related to the Association between pre interventional anxiety score and selected baseline variables.

Chi-square showed There is no statistically significant association was found between pre interventional anxiety and selected baseline variables such as age (χ2=4.194, df=3, p>0.05), gender(χ2=0.575, df=1, p>0.05), marital status (χ2=2.960, df=3, p>0.05), education (χ2=1.256, df=5, p>0.05) , monthly income in rupees (χ2=9.829, df=5, p>0.05) ,occupation (χ2=3.233 ,df=2, p>0.05) habits (χ2=0.387, df=4, p>0.05), place of living (χ2=0.113, df=1, p>0.05),previous history of hospitalization (χ2=0.008, df=1, p>0.05), previous history of surgery/invasive procedure (χ2=0.278, df=1, p>0.05). Hence H3 is rejected at 0.05 level of significance and null hypothesis accepted.

DISCUSSION

Anxiety and stress significantly affect the treatment of the CAD, which can lead to an increase in the area of infarction and even to arrhythmia.13 Therefore, independent nursing interventions to decrease anxiety and stress in ICU patients with coronary artery diseases are necessary.

The present study included only patients who had moderate to severe anxiety. In this regard, studies conducted in Iran also indicated that 74% of patients experienced anxiety before angiography.14 An Indian study done among 35 patients undergoing PTCA showed that almost 26 (46.4%) patients had definite anxiety before PTCA assessed using Hospital Anxiety and Depression Scale. The findings emphasized the importance of screening patients selected for cardiac intervention for anxiety because this not only improves the quality of life but also may reduce morbidity and mortality after the intervention.15 Similarly, a descriptive study among 100 convenient sample anxiety was measured using the Spielberger State Anxiety Inventory. The mean (S.D) of anxiety scores was 35.72(11.75). Symptoms of anxiety were common, particularly before PCI.16

Aromatherapy is noninvasive and can be applied continuously to patients who do not have an aversion to the odors. The present study anxiety level was significantly lower than that of the control group. It was supported by a Korean study.1 A nonequivalent control group non synchronized quasi-experiment designed with 56 patients (Experimental -28, Control-28) undergoing PTCA procedure. The anxiety levels were 0.36 (SD, 0.73) in the aromatherapy group and 3.11 (SD, 2.31) in the control group (t = 5.99, P < .001) after the aroma treatment. The changes in anxiety level were 5.10 (SD, 2.06) in the aromatherapy group and 2.07 (SD, 2.55) in the control group. There was a significant reduction in the aromatherapy group compared with the control group (t = −4.90, P < .001). Similarly, lavender aromatherapy lowered the anxiety in cluster randomized controlled trial among 340 patients in the UK.17

In the present study, there is no statistically significant association was found between pre interventional anxiety and selected baseline. In contrast to the present study, a prospective cohort study among 2604 patients showed that female patients reported a significantly higher preprocedure anxiety (50.4±26.5) compared to males (41.5±26.8, p=0.02). Other factors associated with higher levels of anxiety at different time points were age<65years and low level of education.18

Overall, the results of this study indicated that patients undergoing PTCA experience a high percentage of anxiety. Aromatherapy can be used as a complementary therapy to reduce anxiety. Considering the advantages of this method as an easy, inexpensive, safe and noninvasive approach, application of this non-pharmacological method is recommended to reduce patients' anxiety before conducting diagnostic and invasive procedures

ACKNOWLEDGEMENT

The authors thank all the patients, their caregivers, the hospital authorities and the Biostatistics department who helped to complete this study successfully.

Supporting Files
References

1. Mi-Yeon Cho, Eun Sil Min, Myung-Haeng Hur, and Myeong Soo Lee , Effects of Aromatherapy on the Anxiety, Vital Signs, and Sleep Quality of Percutaneous Coronary Intervention Patients in Intensive Care Units, Evid Based Complement Alternat Med. 2013; 2013: 381381. Published online 2013 Feb 17. doi: 10.1155/2013/381381

2. Tarun Khanna, Rangan V. Kasturi, Merlina Manocara. Narayana Hrudayalaya Heart Hospital: Cardiac Care for the poor. N9-505-078, 2005; June 14.

3. Lee WR. Clinical Cardiology. Seoul, Republic of Korea: Korea Medical Book Publisher; 2002.

4. https://www.business-standard.com/article/ pti-stories/angioplasties-performed in-indiarise-by-42-pc-in-2015-nic-116041600486_1.html

5. Han KS, Park YI. The level of anxiety and relating factors of ICU patients. Journal of Korean Academic Society of Nursing Education. 2002;8(1):155–166. [Google Scholar]

6. Debra K, Moser. The Rust of Life, Impact of Anxiety on Cardiac Patients, Anxiety in Persons with Cardiovascular Disease. American Journal of Critical Care. 2007; 16:361-69.

7. Sadigheh Fayazi, ,Monireh Babashahi, Mehdi Rezaei, The effect of inhalation aromatherapy on anxiety level of the patients in preoperative period. Iran J Nurs Midwifery Res. 2011 Autumn; 16(4): 278–283.

8. Itai T1, Amayasu H, Kuribayashi M, Kawamura N, Okada M, Momose A, Tateyama T, Narumi K, Uematsu W, Kaneko S Psychological effects of aromatherapy on chronic hemodialysis patients. Psychiatry Clin Neurosci. 2000 Aug;54(4):393- 7.http://www.ncbi.nlm.nih.gov/pubmed /10997854Karadag E, Samancioglu S, Ozden D, Bakir E. Effects of aromatherapy on sleep quality and anxiety of patients. Nurs Crit Care 2017;22;105–112. [PubMed] [Google Scholar]

9. Lehrner J, Marwinski G, Lehr S, et al. Ambient odors of orange and lavender reduce anxiety and improve mood in a dental office. Physiol Behav 2005;86(1–2):92–95.

10. Hosseini S, Heydari A, Vakili M, et al. Effect of lavender essence inhalation on the level of anxiety and blood cortisol in candidates for open heart surgery. Iran J Nurs Midwifery Res 2016;21(4):397–401. [PMC free article] [PubMed] [Google Scholar]

11. Christensen JP, Kenny JW. Nursing process: Application of conceptual models. 3rd ed. Philadelphia: C. V. Mosby Company; 1990

12. Dunnington CS, Johnson NJ, Finkelmeier BA, Lyons J, Kehoe RF. Patients with heart rhythm disturbances: variables associated with increased psychologic distress. Heart and Lung. 1988;17(4):381–389.

13. Uzun S, Rural H, Uzun M. State and trait anxiety levels before coronary angiography. J Clin Nurs 2008;12: 602-607

14. Suprakash Chaudhury 1, Kalpana Srivastava, Relation of Depression, Anxiety, and Quality of Life with Outcome after Percutaneous Transluminal Coronary Angioplasty ScientificWorldJournal. 2013; 2013: 465979. Published online 2013 Nov 10. doi: 10.1155/2013/465979

15. Trotter R1, Gallagher R, Donoghue J Anxiety in patients undergoing percutaneous coronary interventions. Heart Lung. 2011 MayJun;40(3):185-92. doi: 10.1016/j.hrtlng.2010.05.054. Epub 2010 Aug 17.

16. Kritsidima M1, Newton T, Asimakopoulou K. The effects of lavender scent on dental patient anxiety levels: a cluster randomised-controlled trial. Community Dent Oral Epidemiol. 2010 Feb;38(1):83-7. doi: 10.1111/j.1600- 0528.2009.00511.x. Epub 2009 Nov 23.

17. .Delewi R1, Vlastra W1, Rohling WJ1, Wagenaar TC1, Zwemstra M1, Meesterman MG1, Vis MM1, Wykrzykowska JJ1, Koch KT1, de Winter RJ1, Baan J Jr1, Piek JJ1, Sprangers MA2, Henriques JP3 Anxiety levels of patients undergoing coronary procedures in the catheterization laboratory. Int J Cardiol. 2017 Feb 1;228:926-930. doi: 10.1016/j. ijcard.2016.11.043. Epub 2016 Nov 11

We use and utilize cookies and other similar technologies necessary to understand, optimize, and improve visitor's experience in our site. By continuing to use our site you agree to our Cookies, Privacy and Terms of Use Policies.